The above results demonstrate that KAT5 activity helps orchestrates E2F- and MYC-networks and likely other self-renewal modules (e.g., POU3F2, CD44) in GSC-derived tumors while suppressing the emergence of more indolent GBM tumor subpopulations. This evidence concerns the gene KAT5 and glioblastoma.